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A lagille syndrome (ALGS) results from mutations inJAG1 and NOTCH2 in the Notch signaling
pathway.1,2 These mutations clinically manifest in
various ways, but ALGS is most commonly character-
ized by a paucity of bile ducts in the liver. ALGS often
involves the kidney, which can be characterized by
defects in the glomerular vasculature, podocytes,
proximal tubules, and renal dysplasia. In addition,
altered lipid metabolism in ALGS can cause mesangial
lipidosis in the kidney.1,3 Few case reports describe the
renal manifestations of ALGS.1,3–10 Here we report an
Alagille syndrome patient with renal dysplasia, renal
lipidosis, and bile cast nephropathy. This case high-
lights the spectrum of renal pathologic ﬁndings due to
Alagille syndrome that can manifest as a result of de-
fects in the Notch signaling pathway.
CASE PRESENTATION
A 19-year-old male patient with ALGS was treated with
a partial external biliary diversion when he was 1 year
of age, and did not require liver transplantation. He
had Henoch–Schönlein purpura at age 6 years, with
acute kidney injury and hypertension that resolved. He
also had a history of peripheral pulmonic stenosis,
splenomegaly, and nephrolithiasis. He was lost to
follow-up from Pediatric Nephrology. His last
nephrology visit was 10 years prior to this admission,
at which time his plasma creatinine was 0.7 mg/dl,
corresponding to an estimated glomerular ﬁltration rate
(eGFR) of 68 ml/min/1.73 m2. His last visit with Hep-
atology was 2 years prior to this admission, at which
time his laboratory values were as follows: total bili-
rubin, 18.6 mg/dl; direct bilirubin, 13.8 mg/dl; AST,
146 mg/dl; ALT, 178 mg/dl; alkaline phosphatase, 731
mg/dl; blood urea nitrogen (BUN), 33 mg/dl; andInternational Reports (2016) -, -–-plasma creatinine, 1.12 mg/dl, corresponding to an
eGFR of 56 ml/min/1.73 m2.
He presented on this admission with left-sided
abdominal pain, gross hematuria, weakness, con-
stipation, and decreased appetite. He had an elevated
serum creatinine of 6 mg/dl, BUN of 134 mg/dl, total
bilirubin of 33 mg/dl, and direct bilirubin of 26.1 mg/dl.
However, his liver enzymes (AST, 102 mg/dl; ALT,
161 mg/dl; alkaline phosphatase, 627 mg/dl) and
platelet count (69  103/ml) were not remarkably
different from his usual baseline levels (Table 1). His
total cholesterol was unchanged from prior values at
138 mg/dl; however, his high-density lipoprotein
(HDL) cholesterol had decreased from 17 mg/dl
to <5 mg/dl. His serum albumin was low at 2.6 mg/dl
(previously 3.9 mg/dl 2 years before admission). His
urinalysis was notable for numerous red blood cells
(not quantiﬁed), 3 to 5 white blood cells/hpf, and new
onset of proteinuria with a urine protein/creatinine of
0.8 mg/mg. His kidney insufﬁciency did not improve,
and he was started on hemodialysis. A kidney biopsy
was performed.
Renal Biopsy Findings
The light microscopic sample contained 11 glomeruli,
of which 5 glomeruli were globally sclerosed. The
patent glomeruli demonstrated diffuse vacuolization of
the glomerular basement membranes and subepithelial
“spike” formation highlighted on the methenamine
silver stain (Figure 1). Focally, mesangial cells and
podocytes showed vacuolization, and some podocytes
contained yellow-brown pigment. Interstitial foam cells
were not present. The cortex contained patchy and
focally marked interstitial ﬁbrosis and tubular atrophy
with normally developed tubules. In contrast, some
medullary tubules were immature and focally sur-
rounded by spindled cells, which was consistent with1
Figure 2. Several immature tubules and a large bile cast is present
on the left (hematoxylin and eosin, original magniﬁcation 40).
Table 1. Summary of case patient’s laboratory results
Laboratory variable Current value Previous value
Creatinine 6 mg/dl 1.12 mg/dl
Serum albumin 2.6 mg/dl 3.9 mg/dl
Total bilirubin 33 mg/dl 18.6 mg/dl
Direct bilirubin 26.1 mg/dl 13.8 mg/dl
AST 102 mg/dl Unchanged
ALT 161 mg/dl Unchanged
Alkaline phosphatase 627 mg/dl Unchanged
Platelets 69 x 103/ml Unchanged
Total cholesterol 138 mg/dl Unchanged
HDL cholesterol <5 mg/dl 17 mg/dl
Urinalysis
Red blood cells Numerous (not quantiﬁed) 0/hpf
White blood cells 3–5/hpf 0/hpf
Urine protein/creatinine 0.8 g/g Normal range
ALT, alanine aminotransferase; AST, aspartate transaminase; HDL, high-density lipo-
protein; hpf, high-power ﬁeld.
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segments contained yellowbrown casts that were
consistent with bile/bilirubin casts (Figure 2), and some
tubular epithelial cells contained yellowbrown cyto-
plasmic inclusions.
Immunoﬂuorescence microscopy (scale, 04þ) of 3
glomeruli (1 globally sclerotic) showed no staining of
the glomeruli, tubular basement membranes, or inter-
stitium for IgG, IgA, IgM, C3, C1q, ﬁbrinogen, k or l
light chains, or albumin. Tubular casts stained for IgA
and k and l light chains. The arterioles stained for C3.Figure 1. Glomerular basement membranes show a prominent
vacuolated appearance and focal subepithelial “spike” formation,
which appears identical to membranous nephropathy (Jones
methenamine silver, original magniﬁcation 600).
2Ultrastructural evaluation demonstrated diffuse
deposition of lamellated electron-dense deposits and
vacuoles, which were consistent with lipid droplets, in
the glomerular basement membranes (Figure 3). Occa-
sional podocytes and mesangial and endothelial cells
contained lipid vacuoles. There were also occasional
lipid vacuoles present in the tubular and peritubular
capillary basement membranes, interstitium, and
smooth muscle cells in arterioles (Figure 4). Immune-
type electron-dense deposits were not present. The
ﬁnal diagnosis was basement membrane and mesangial
lipidosis consistent with renal involvement by Alagille
syndrome, with additional components of bile cast
nephropathy and renal dysplasia.Figure 3. Numerous lipid vacuoles with characteristic electron
dense and lucent areas are embedded in the glomerular basement
membranes and some mesangial cells. Some of the lipid vacuoles
are subepithelial, intramembranous, or subendothelial in location
(bar ¼ 2 mm).
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Figure 4. Similar lipid vacuoles also accumulate within the tubular
basement membranes (original magniﬁcation 5000).
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he was discharged on maintenance outpatient
hemodialysis.
DISCUSSION
ALGS is an autosomal-dominant inherited disease
caused by mutations in either JAG1 or NOTCH2 genes
involving 94% and 0.8% of probands, respectively.1,2
This disorder can affect multiple organs, including the
liver, heart, skeleton, eye, face, and kidneys. Clinical
penetrance is variable, but most patients present with
cholestasis caused by a paucity of intralobular bile
ducts.3 Pruritis, xanthomas, and failure to thrive are
also common and result from the bile duct dysplasia in
the liver.1 Cholestasis can progress to end-stage liver
disease, and liver transplantation is required in 20% to
50% of cases.4 Congenital cardiac involvement is
common, usually involving the pulmonary arteries and
the pulmonary valves, and tetralogy of Fallot is often
present.11 The most common skeletal abnormality is a
vertebral sagittal cleft, called the butterﬂy vertebrae.
Posterior embryotoxon (prominence of Schwalbe ring)
can occur in the eye. ALGS patients can have a char-
acteristic facies: triangular face shape with a prominent
forehead, hypertelorism, pointed nose, and saddle nose
with bulbous tip.1 Clinical diagnosis is based on the
absence of bile ducts in association with at least 3
additional clinical features among those listed above.
Renal and vascular abnormalities are present in 40% toKidney International Reports (2016) -, -–-70% and 10% to 15% of patients, respectively.1,5
Clinical renal ﬁndings reported include horseshoe
kidney, congenital single kidney, a duplex collecting
system, renal dysplasia (with or without cysts), renal
tubular acidosis, ureteropelvic or vesicoureteral uri-
nary obstruction, vesicoureteral reﬂex, and transient
azotemia.1,7,8 These renal abnormalities can cause sec-
ondary clinical ﬁndings, including metabolic bone
disease caused by renal tubular acidosis.12
More than 430 mutations in JAG1 have been iden-
tiﬁed, and there are no mutational hotspots. These
mutations often result in a truncated protein that leads
to haploinsufﬁciency.5 JAG1 is expressed in many
adult tissues, including heart, skeletal muscle, kidney,
and bone marrow, and in fetal heart, liver, lung, and
kidney.11 The expression of notch2 and jagged1 is
complex and varies during the different stages of
kidney development. In the kidney, the ureteric bud
arises from the Wolfﬁan duct, invades the adjacent
metanephric blastemal, undergoes repeated branching,
and eventually forms the collecting ducts, calyces,
pelvis, and ureter. The ureteric branch tips then induce
mesenchymal cells to form nephrogenic precursors
including the cap mesenchyme. Notch2 is expressed in
the ureteric bud and cap mesenchyme and immature
proximal tubules, and notch2 and jagged1 are both
expressed in the subsequent epithelial vesicle, comma-
shaped body, and S-shaped body. In the mature
nephron, glomerular and tubular epithelial cells ex-
press notch2, whereas jagged1 is expressed in
glomerular endothelial cells and collecting ducts. In
mice, this variable expression results in glomerular,
podocyte, and proximal tubule defects in animals with
JAG1 and NOTCH2 mutations.5,13 Homozygous
NOTCH2 mutations and homozygous JAG1 null mu-
tations are embryonically lethal in mice due to vascular
defects in the metanephric kidney. Mice heterozygous
for mutations in both JAG1 and NOTCH2 serve as a
model for ALGS, and in these mice, the early stages of
kidney development occur normally, but podocytes
and proximal tubules do not form, and the glomerulus
has vascularization defects.5,14,15
The role of JAG1 and NOTCH2 in kidney develop-
ment likely leads to the clinical and pathologic renal
manifestations in ALGS that have been described.1,3–10
The defects in proximal nephron development due to
JAG1 or NOTCH2 may account for renal dysplasia,1 as
seen in our patient. Renal dysplasia is present in most
ALGS patients, which is deﬁned by the presence of
immature tubules surrounded by collarettes of
condensed mesenchyme with or without immature
cartilage or cysts on imaging (increased echogenicity
with or without renal cysts and small size).1,16,17 Renal
tubular acidosis, ureteropelvic or vesicoureteral3
Table 2. Teaching points regarding Alagille syndrome
Chronic kidney disease is common in patients with Alagille syndrome, and 40% of
patients have renal abnormalities.
There is a spectrum of histologic renal ﬁndings in Alagille syndrome, including renal
dysplasia that likely results from mutations in the Notch signaling pathway.
Other renal histologic ﬁndings include mesangiolipidosis and bile cast nephropathy,
highlighting the harmful effects of defects in the liver on the kidney
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occur.1 Chronic kidney disease is common in ALGS,
with 1 study reporting a calculated glomerular ﬁltra-
tion rate (GFR) of <90 ml/min in 18% of ALGS pa-
tients, which did not improve after liver
transplantation.4 Multiple factors likely contribute to
the progressive renal dysfunction that occurs even af-
ter liver transplantation, including the effects of long-
term immunosuppression.
In addition to renal dysplasia, our patient had bile cast
nephropathy, which occurs in patients with severe liver
dysfunction.High levels of serum total bilirubin andbile
acids result in direct tubular injury, and formation of
bile casts leads to nephron obstruction. It can occur in a
wide spectrum of severe liver dysfunction, including
cholestatic/obstructive jaundice,18 and to our knowl-
edge this is the ﬁrst report in the setting of ALGS.
There are only a few reports of ALGS, but all
describe glomerular lipid deposition. Alagille et al.
described mesangiolipidosis in 17 of 23 studied pa-
tients, and electron microscopy demonstrated lipid
vacuoles in the mesangial matrix.1 Another study re-
ported similar pathologic ﬁndings in 18 of 26 patients,
and found that the extent of mesangiolipidosis was
related to the degree of cholestasis, with more promi-
nent ﬁndings in patients with high bilirubin, high total
cholesterol, and high triglyceride levels.7 Although the
level of cholestasis and hyperlipidemia in our patient
was relatively lower than in prior reports, the patient is
signiﬁcantly older than those in the other reports, and
the long-term cumulative impact of liver dysfunction
could have resulted in the current biopsy ﬁndings.
Chung-Park et al. reported mesangiolipidosis but also
lipid deposition in the glomerular basement membranes
that resembled the changes seen in membranous ne-
phropathy on PAS and methenamine silver stains,
similar to ﬁndings in our patient. Ultrastructurally,
there were occasional mesangial lipid deposits and
numerous intramembranous, subepithelial, and sub-
endothelial lipid deposits. Lipid deposits can also be
present in the tubular basement membranes.6 Similar
ﬁndings of diffuse glomerular basement membrane
thickening and subepithelial “spikes” on methenamine
silver stain were also reported in 2 of 4 cases by Russo
et al. and in 1 case by Davis et al.8,10
The most striking pathologic ﬁnding in advanced
ALGS is the presence of numerous lipid vacuoles (lip-
idosis) embedded within the glomerular basement
membrane (GBM), which is identical in appearance to
familial lecithincholesterol acyltransferase (LCAT)
deﬁciency. Lecithincholesterol acyltransferase is
required for the esteriﬁcation of cholesterol, and deﬁ-
ciency in this disorder leads to excess free cholesterol
and lecithin in the blood. In the kidney, this has been4reported to result in subepithelial lipid deposition in
the glomerular basement membranes resembling mem-
branous nephropathy, deposition in podocyte cyto-
plasm, deposition in tubular basement membranes, and
deposition in capillary endothelial cytoplasm.19,20 In
our patient, the lipid vacuoles could be observed in
direct contact with either the capillary lumen or the
podocyte cell membrane, which demonstrates these
sizeable objects traversing the GBM. Although red
blood cells must also traverse the entire thickness of
the GBM, this has rarely been reported in thin base-
ment membrane nephropathy.21 Although hyperlipid-
emia is characteristic of nephrotic syndrome, GBM
lipidosis has never been seen in the setting of minimal
change disease, focal segmental glomerulosclerosis, or
membranous nephropathy. Therefore, additional aber-
rations involving lipid biology may be necessary.
In conclusion, our case illustrates many key histo-
pathologic features of Alagille syndrome: renal
dysplasia due to the disruption of the Notch signaling
pathway in early nephron development and glomer-
ular, tubular basement membrane, and vascular lipid
deposition as a consequence of cholestasis resulting
from bile duct dysplasia in the liver (Table 2). In
addition, our case also demonstrates bile cast ne-
phropathy, further highlighting the harmful cumula-
tive impact of liver dysfunction in the kidney.DISCLOSURE
All the authors declared no competing interests.
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